Search Results 431-440 of 16582 for ������������KA���:ZA31���24������ ���������������������������������

  1. Publications - Garvan C. Kane, M.D., Ph.D. - Mayo Clinic

    Young KA, Rodeheffer RJ, Bird JG, Miranda WR ... 2025 Feb 24; 17 (1):14. View PubMed; Picano E ... 2023 Aug 23; 24(9):1210-1221. View PubMed; Reddy P ...

  2. Vaginal bleeding Causes - Mayo Clinic

    https://www.uptodate.com/contents/search. Accessed Jan. 24, 2023. AskMayoExpert. Abnormal uterine bleeding: Premenopausal women (adult). Mayo Clinic; 2022.

  3. A Study to Evaluate the Effectiveness and Safety of Triple Combination Therapy in High Risk Crohn's Disease (CD) - Mayo Clinic

    Has an initial diagnosis of Chrohn's Disease (CD) established within 24 months prior to screening with involvement of the ileum and/or colon that can be ...

  4. A Study of Endocrine Encounters - Mayo Clinic

    Rochester, Minnesota: 24-012956. About this study. The purpose of this study is to to improve care for patients with endocrine conditions while reducing ...

  5. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    ... 24; Month 6) Visit 9 (Week 52; Month 12). Visit 10 (Week 104, Month 24). Predictive Role of Non-Invasive Glucose Assessment During Pregnancy. Rochester, Minn ...

  6. A Study of Lu AF82422 in participants with Multiple System Atrophy - Mayo Clinic

    Scottsdale/Phoenix, Arizona: 24-008235. Sponsor Protocol Number: 20432A. About this study. The purpose of this study is to evaluate the efficacy and safety of ...

  7. Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors - Mayo Clinic

    Chemotherapy drugs, such as capecitabine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping ...

  8. Whipple procedure - Doctors & Departments - Mayo Clinic

    In: Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 21st ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed March 24, ...

  9. A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Patients With Advanced Solid Tumors - Mayo Clinic

    Rochester, Minnesota: 24-009329; Jacksonville, Florida: 24-009329. NCT ID: NCT05932862. Sponsor Protocol Number: XL309-101. About this study. This is a FIH ...

  10. Fucoidan for Patients With Chemotherapy-Related Fatigue - Mayo Clinic

    Scottsdale/Phoenix, Arizona: 24-004592. NCT ID: NCT06855524. Sponsor Protocol Number: MC231007. About this study. The purpose of this study is to determine the ...